Quality Systems – Page 53

Unplanned maintenance intervention during inspection walkthrough – preventing repeat deviations via reliability strategy

Strategies to Prevent Repeat Deviations from Unplanned Maintenance Interventions during Inspections Unplanned maintenance interventions during inspection walkthroughs can lead to critical deviations, compliance issues, and potential regulatory scrutiny. This article…

Deficiency response rejected by agency during variation planning – FDA/EMA expectations and how to respond

“`html Addressing Agency Rejections of Deficiency Responses during Variation Planning In the pharmaceutical industry, receiving a deficiency response from regulatory agencies such as the FDA or EMA during the variation…

Alarm bypass detected during inspection walkthrough – preventing repeat deviations via reliability strategy

Managing Alarm Bypass Issues During Inspections to Avoid Recurring Deviations In pharmaceutical manufacturing, adherence to Good Manufacturing Practices (GMP) is paramount to ensure product quality, safety, and compliance with regulatory…

Agency feedback misinterpreted during post-approval maintenance – documentation gaps inspectors question

“`html Understanding Misinterpretations of Agency Feedback in Post-Approval Maintenance Pharmaceutical companies often encounter challenges surrounding agency feedback during post-approval maintenance. Misinterpretations of this feedback can lead to documentation gaps that…

Alarm bypass detected during inspection walkthrough – calibration/PM evidence pack checklist

“`html Addressing Alarm Bypass Issues Detected During Inspection Walkthroughs Pharmaceutical manufacturing is a heavily regulated industry where operational integrity is vital. Alarm systems are critical components that ensure safety and…

Inconsistent global strategy during global submissions – CAPA and strategy reset

Addressing Inconsistent Global Strategies During Submissions: A Comprehensive CAPA Approach In the highly regulated world of pharmaceutical manufacturing, global submissions can reveal inconsistencies in practices that may jeopardize compliance with…

Spare part not qualified during routine operations – how to defend maintenance decisions to inspectors

Defending Maintenance Decisions Regarding Unqualified Spare Parts During Routine Operations The occurrence of unqualified spare parts during routine operations can pose significant challenges. Maintenance teams may sometimes replace parts quickly…

Commitment timelines missed during post-approval maintenance – FDA/EMA expectations and how to respond

Addressing Commitment Timelines Missed During Post-Approval Maintenance: An Investigative Approach In the dynamic environment of pharmaceutical manufacturing, failing to meet commitment timelines during post-approval maintenance can trigger significant regulatory scrutiny.…

Calibration failure discovered during changeover maintenance – root cause approach for recurring failures

Addressing Calibration Failures During Changeover Maintenance: A Root Cause Approach In pharmaceutical manufacturing, calibration is essential for maintaining the accuracy and reliability of equipment that plays a critical role in…

Regulatory intelligence not applied during global submissions – approval risk analysis and mitigation

Assessing the Risks of Unutilized Regulatory Intelligence During Global Submissions The pharmaceutical landscape is increasingly competitive and complex, with successful global submissions hinging on myriad factors, including regulatory intelligence. When…

Calibration failure discovered during seasonal HVAC load changes – CAPA that links maintenance to product quality risk

Understanding Calibration Failures During Seasonal HVAC Load Changes and its Impact on Product Quality In pharmaceutical manufacturing, maintaining consistent environmental conditions is critical to ensuring product quality and compliance with…

Deficiency response rejected by agency during variation planning – documentation gaps inspectors question

Addressing Agency Rejections of Deficiency Responses in Variation Planning In the fast-paced and highly regulated pharmaceutical industry, the rejection of deficiency responses during variation planning can significantly impact product lifecycle…